REGULATORY COMPLIANCE – Page 55

How to Investigate Documentation Deviations Using Root Cause Analysis

The first indication of a potential issue often comes from the manufacturing floor or quality control lab. In this scenario, team members observed the following signals:Click to read the full…

ALCOA+ Checklist for Batch Record Review Before Release

Identification of documentation errors during batch record reviews can occur through various signals, often observed on the production floor or within laboratory environments. Common symptoms include:Click to read the full…

GDP Compliance for SOPs, Forms, and Attachments

Identifying symptoms of GDP non-compliance is the first step in addressing the problem. Common indicators on the manufacturing floor or in the laboratory may include:Click to read the full article.

How to Strengthen GDP Culture Across Pharma Operations

Recognizing symptoms or signals indicative of GDP-related issues is fundamental for swift corrective actions. Common signals include:Click to read the full article.

Good Documentation Practices During Regulatory Inspections

Documentation errors manifest in various forms that can signal potential deficiencies in compliance, affecting data integrity and overall quality assurance. Symptoms might include:Click to read the full article.

GDP CAPA Examples for Repeated Documentation Errors

The scenario involved a mid-sized pharmaceutical company producing oncology products. Over the course of several months, the Quality Control (QC) unit observed inconsistencies during routine batch record reviews. The signals…

ALCOA+ Roadmap for Paperless and Hybrid GMP Sites

Identifying symptoms of documentation errors in GMP environments is the first step toward resolving issues stemming from poor practices. The following are common indicators that signal potential compliance failures related…

Validation and Qualification Compliance Requirements for GMP Facilities

Recognizing symptoms of validation and qualification non-compliance is the first step in a corrective workflow. Here are several signals to monitor:Click to read the full article.

How to Build a Risk Based Validation Compliance Program

Recognizing symptoms of potential issues in validation compliance is the first step towards effective management and remediation. These signals can manifest in various forms, including:Click to read the full article.

Validation Qualification Compliance Checklist for FDA EMA and MHRA Inspections

Essential Steps for Ensuring Validation Qualification Compliance in Pharma Inspections In the pharmaceutical industry, ensuring compliance with validation and qualification processes is paramount, especially during regulatory inspections by bodies such…

How to Align Validation Practices with Annex 15 and FDA Expectations

Aligning Validation Practices to Meet FDA and Annex 15 Standards In the pharmaceutical industry, ensuring compliance with both FDA validation expectations and Annex 15 is a critical aspect of maintaining…

Qualification Compliance Gaps in Equipment Utility and Process Systems

Identifying the first signs of potential gaps in validation compliance is crucial. Symptoms on the manufacturing floor or in the lab may manifest as:Click to read the full article.